Linda Dujack, retired from Johnson & Johnson (J&J), was Vice President for Product Evaluation and University Relations, where she was responsible for proactively establishing relationships with universities, small bio-tech companies, and major pharmaceutical companies in order to identify new opportunities that would merit participation by J&J.
Prior to that Linda served as Vice President of Worldwide Regulatory Affairs at J&J, resulting in many successful submissions and approvals. She was also part of the licensing/financing team responsible for evaluating new product/technology opportunities and developing R&D cost models for the financial evaluation of these opportunities. At J&J Linda also served as Executive Director for the Erythropoietin (EPO) Worldwide Development Project and Director for Medical Services and Support, a department she established for Ortho Biotech.
Prior to joining J&J, Linda was Deputy Director for the Food and Drug Administration in the Center for Biologics Evaluation and Research. She was also Vice President for Regulatory Affairs and Special Projects at Geritech, a small start-up company whose technology came from Rockefeller University. Linda was also Associate Director of Regulatory Affairs at Hoffmann La-Roche. Prior to that she was a Senior Staff Officer at the National Academy of Sciences/Institute of Medicine.
Linda earned her PhD in biology from Georgetown University with distinction and her BS degree also in biology from Ramapo College of New Jersey with honors. She taught biology and cell biology as an Assistant Professor at Hood College in Frederick, MD.